Phase 2 Clinical Trial Results The pivotal Phase 2 trial (Jastreboff et al., 2023, PMID: 37351564) published in *The New England Journal of Medicine* enrolled 338 adults with obesity
When you look back 40 years on the impact of certain medications have had on health outcomes, statins are a great example
If you have a history of high or low blood pressure, talk to your doctor about how much caffeine is safe for you while on Tadalafil
OptiNOs, our clinically tested nitric oxide booster & muscle builder, turns on pathways in our body that signal the production of nitric oxide and protein synthesis
Ozempic (Semaglutide) mimics a hormone (glucagon-like peptide-1) that helps regulate glucose metabolism and appetite
Its scope is narrow: it applies only when a patient is on ongoing insulin therapy as part of chronic disease management